October 3, 1996New England Journal of Medicine7,505 citationsOpen Access
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
View Full Paper
Structured PICO
Does pravastatin reduce coronary events in patients after myocardial infarction with average cholesterol levels?
P
Population
Patients after myocardial infarction with average cholesterol levels
I
Intervention
Pravastatin (cholesterol-lowering therapy)
O
Outcome
Coronary eventshard clinical
Pravastatin provides clinical benefit in reducing coronary events for post-myocardial infarction patients even when their cholesterol levels are average.
Abstract
These results demonstrate that the benefit of cholesterol-lowering therapy extends to the majority of patients with coronary disease who have average cholesterol levels.